Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 601–700 of 1,065
Microbial transmission, colonisation and succession: from pregnancy to infancy
Xiao, L., & Zhao, F. (2023) · Gut · doi:10.1136/gutjnl-2022-328970 · Cited by 173
Rodes, L. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1205.05018 · Cited by 173
“Gut-derived lipopolysaccharides (LPS) are critical to the development and/or progression of a variety of human conditions, such as chronic low-grade inflammation [5], metabolic diseases [5, 6, 8], and liver diseases [1, 34].”
BackgroundMethodInfluentialToll-like Receptor 4 Deficiency Promotes the Alternative Activation of Adipose Tissue Macrophages
Orr, J. S., Puglisi, M. J., Ellacott, K. L. J., Lumeng, C. N., Wasserman, D. H., & Hasty, A. H. (2012) · Diabetes · doi:10.2337/db11-1595 · Cited by 173
“Irrespective of whether SFAs act as a TLR4 ligand, several lines of evidence suggest a much more complex and multifaceted immunomodulatory role for dietary fatty acids, such as inducing a shift to gram-negative intestinal microbiota and increasing gut permeability (28).”
BackgroundSolas, M., Milagro, F. I., Ramírez, M. J., & Martínez, J. A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.005 · Cited by 173
Sohet, F. M., Neyrinck, A. M., Pachikian, B. D., de Backer, F. C., Bindels, L. B., Niklowitz, P., Menke, T., Cani, P. D., & Delzenne, N. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.008 · Cited by 171
Self-citationPejnovic, N. N., Pantic, J. M., Jovanovic, I. P., Radosavljevic, G. D., Milovanovic, M. Z., Nikolic, I. G., Zdravkovic, N. S., Djukic, A. L., Arsenijevic, N. N., & Lukic, M. L. (2013) · Diabetes · doi:10.2337/db12-0222 · Cited by 172
“HFD strongly increases intestinal permeability and increases blood levels of endotoxin (43).”
BackgroundLin, H., An, Y., Hao, F., Wang, Y., & Tang, H. (2016) · Scientific Reports · doi:10.1038/srep21618 · Cited by 172
Jennis, M., Cavanaugh, C. R., Leo, G. C., Mabus, J. R., Lenhard, J., & Hornby, P. J. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13178 · Cited by 171
Ott, B., Skurk, T., Hastreiter, L., Lagkouvardos, I., Fischer, S., Büttner, J., Kellerer, T., Clavel, T., Rychlik, M., Haller, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12109-9 · Cited by 170
Non-alcoholic steatohepatitis: a microbiota-driven disease
Moschen, A. R., Kaser, S., & Tilg, H. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.05.009 · Cited by 170
The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract
Bilski, J., Mazur-Bialy, A., Wojcik, D., Zahradnik-Bilska, J., Brzozowski, B., Magierowski, M., Mach, T., Magierowska, K., & Brzozowski, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/9074601 · Cited by 170
“Moreover, endotoxemia has been suggested to play a crucial role in pathogenesis of metabolic syndrome [78, 79].”
BackgroundFei, N., Bruneau, A., Zhang, X., Wang, R., Wang, J., Rabot, S., Gérard, P., & Zhao, L. (2020) · mBio · doi:10.1128/mbio.03263-19 · Cited by 168
Liu, W., Zhao, S., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Hong, J., & Liu, R. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601082 · Cited by 169
Van Hul, M., Geurts, L., Plovier, H., Druart, C., Everard, A., Ståhlman, M., Rhimi, M., Chira, K., Teissedre, P.-L., Delzenne, N. M., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2017 · Cited by 168
Self-citationInnate immune receptors in platelets and platelet-leukocyte interactions
Dib, P. R. B., Quirino-Teixeira, A. C., Merij, L. B., Pinheiro, M. B. M., Rozini, S. V., Andrade, F. B., & Hottz, E. D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0620-701r · Cited by 166
Corb Aron, R. A., Abid, A., Vesa, C. M., Nechifor, A. C., Behl, T., Ghitea, T. C., Munteanu, M. A., Fratila, O., Andronie-Cioara, F. L., Toma, M. M., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030618 · Cited by 169
“Researchers have recently reported imbalances in intestinal microbiota, disease sensitivity, immune deficiencies, and, most specifically, obesity and resistance to insulin [18].”
BackgroundThe Gut Microbiome in Hypertension: Recent Advances and Future Perspectives
Avery, E. G., Bartolomaeus, H., Maifeld, A., Marko, L., Wiig, H., Wilck, N., Rosshart, S. P., Forslund, S. K., & Müller, D. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318065 · Cited by 168
Patterson, E., Ryan, P. M., Wiley, N., Carafa, I., Sherwin, E., Moloney, G., Franciosi, E., Mandal, R., Wishart, D. S., Tuohy, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51781-x · Cited by 168
Spruss, A., Kanuri, G., Stahl, C., Bischoff, S. C., & Bergheim, I. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.75 · Cited by 168
A 360-degree overview of paediatric NAFLD: Recent insights
Nobili, V., Svegliati-Baroni, G., Alisi, A., Miele, L., Valenti, L., & Vajro, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.003 · Cited by 171
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes
Devaraj, S., Tobias, P., & Jialal, I. (2011) · Cytokine · doi:10.1016/j.cyto.2011.03.023 · Cited by 168
Obesity, adipokines and neuroinflammation
Aguilar-Valles, A., Inoue, W., Rummel, C., & Luheshi, G. N. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.023 · Cited by 168
“…et al., 2007), and/or changes in microbiota that have been linked to the underlying inflammatory response in obese animals and humans (Burcelin, 2012; Cani et al., 2007, 2008); ▪ increased sympathetic activity (Canale et al., 2013), although it still needs to be clarifiedwhether this has a…”
BackgroundA natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review
Torres-Fuentes, C., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2015) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000099 · Cited by 167
Guillemot-Legris, O., Masquelier, J., Everard, A., Cani, P. D., Alhouayek, M., & Muccioli, G. G. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0666-8 · Cited by 168
“This will lead to a disruption of the intestinal epithelium integrity that in turn will result in increased passage of endotoxins (such as lipopolysac-charides (LPS)) into the bloodstream that will then fuel the peripheral inflammatory tone [4, 12, 13].”
Self-citationFernandes, R., Viana, S. D., Nunes, S., & Reis, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 168
Challenging homeostasis to define biomarkers for nutrition related health
van Ommen, B., Keijer, J., Heil, S. G., & Kaput, J. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800390 · Cited by 167
Harsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
“Antibiotic therapy with ampicillin and neomycin (broad-spectrum antibiotics that are poorly absorbed) was associated with changes in the gut microbiota and endotoxemia during the ingestion of the high-fat diet [53].”
BackgroundGut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity
Stephens, R. W., Arhire, L., & Covasa, M. (2018) · Obesity · doi:10.1002/oby.22179 · Cited by 166
“The concept of metabolic endotoxemia was initially described in mice as the ability of bacterial LPS to trigger a systemic inflammatory status (73) by bacterial translocation to blood flow and tissues.”
BackgroundAntibiotic effects on gut microbiota and metabolism are host dependent
Fujisaka, S., Ussar, S., Clish, C., Devkota, S., Dreyfuss, J. M., Sakaguchi, M., Soto, M., Konishi, M., Softic, S., Altindis, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86674 · Cited by 166
“Multiple mechanisms have been suggested including the effects of bacterially released LPSs (10), the metabolism of short-chain fatty acids and bile acids (11, 12), and the effects on the host’s immune system (13).”
BackgroundThe Role of Dietary Nutrients in Inflammatory Bowel Disease
Sugihara, K., Morhardt, T. L., & Kamada, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03183 · Cited by 166
Toubal, A., Kiaf, B., Beaudoin, L., Cagninacci, L., Rhimi, M., Fruchet, B., da Silva, J., Corbett, A. J., Simoni, Y., Lantz, O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17307-0 · Cited by 165
Wang, L., Li, P., Tang, Z., Yan, X., & Feng, B. (2016) · Scientific Reports · doi:10.1038/srep33251 · Cited by 165
Role of intestinal inflammation as an early event in obesity and insulin resistance
Ding, S., & Lund, P. K. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283478727 · Cited by 165
“Antibiotics, prebiotics or probiotic bacteria appear to ameliorate this effect and protect against weight gain, systemic inflammation and insulin resistance (26, 30).”
Matheus, V., Monteiro, L., Oliveira, R., Maschio, D., & Collares-Buzato, C. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708188 · Cited by 165
Gut microbiome-Mediterranean diet interactions in improving host health
Nagpal, R., Shively, C. A., Register, T. C., Craft, S., & Yadav, H. (2019) · F1000Research · doi:10.12688/f1000research.18992.1 · Cited by 164
Cremonini, E., Daveri, E., Mastaloudis, A., Adamo, A. M., Mills, D., Kalanetra, K., Hester, S. N., Wood, S. M., Fraga, C. G., & Oteiza, P. I. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101269 · Cited by 163
“These three components of intestinal physiology are interrelated: i) intestinal permeabilization can lead to the paracellular transport of endotoxins present in food or those generated by the luminal microbiota, which once in the circulation, can trigger systemic inflammatory responses [5,7,8]; ii) modifications in mi…”
BackgroundNicoletti, A., Ponziani, F. R., Biolato, M., Valenza, V., Marrone, G., Sganga, G., Gasbarrini, A., Miele, L., & Grieco, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4814 · Cited by 164
Zhuang, P., Li, H., Jia, W., Shou, Q., Zhu, Y., Mao, L., Wang, W., Wu, F., Chen, X., Wan, X., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01126-6 · Cited by 163
Lee, S. J., Bose, S., Seo, J.-G., Chung, W.-S., Lim, C.-Y., & Kim, H. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.12.006 · Cited by 164
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
“It was revealed that while plasma LPS levels were increased following high-fat feeding relative to controls, this result was overturned in high-fat diet-fed mice following antibiotic treatment((72)).”
BackgroundToll-Like Receptor–Gut Microbiota Interactions: Perturb at Your Own Risk!
Carvalho, F. A., Aitken, J. D., Vijay-Kumar, M., & Gewirtz, A. T. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153330 · Cited by 164
Lau, E., Marques, C., Pestana, D., Santoalha, M., Carvalho, D., Freitas, P., & Calhau, C. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0089-7 · Cited by 164
Fang, W., Xue, H., Chen, X., Chen, K., & Ling, W. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxy324 · Cited by 163
Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet
Takemura, N., Okubo, T., & Sonoyama, K. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009377 · Cited by 163
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
Miele, L., Giorgio, V., Alberelli, M. A., De Candia, E., Gasbarrini, A., & Grieco, A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0671-z · Cited by 163
Gut microbiota and probiotics: Focus on diabetes mellitus
Bordalo Tonucci, L., Dos Santos, K. M. O., De Luces Fortes Ferreira, C. L., Ribeiro, S. M. R., De Oliveira, L. L., & Martino, H. S. D. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.934438 · Cited by 164
“A previous study showed that the decrease in the number of Prevotella spp. was significantly associated with the decrease in metabolic endotoxemia and inflammation in ob/ob mice with glucose intolerance (Cani et al., 2008).”
BackgroundResultInfluentialInfluence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
Carvalho, B. M., & Abdalla Saad, M. J. (2013) · Mediators of Inflammation · doi:10.1155/2013/986734 · Cited by 163
Dao, T.-M. A., Waget, A., Klopp, P., Serino, M., Vachoux, C., Pechere, L., Drucker, D. J., Champion, S., Barthélemy, S., Barra, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020700 · Cited by 161
“This diet induces diabetes before the onset of obesity [4,5,26,27].”
BackgroundSelf-citationYang, C., Deng, Q., Xu, J., Wang, X., Hu, C., Tang, H., & Huang, F. (2019) · Food Research International · doi:10.1016/j.foodres.2018.10.003 · Cited by 163
Probiotics for weight loss: a systematic review and meta-analysis
Park, S., & Bae, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.05.008 · Cited by 161
“[12] Cani PD, Bibiloni R, Knauf C,Waget A, Neyrinck AM, Delzenne NM.”
BackgroundInfluentialGhosh, S. S., Bie, J., Wang, J., & Ghosh, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108577 · Cited by 161
Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes
Castanon, N., Lasselin, J., & Capuron, L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00074 · Cited by 161
“While it is likely that central inflammation in obesity results from adiposity-related systemic inflammatory processes, the increases in circulating levels of TLR4 ligands and free saturated fatty acids following impaired gut permeability in high-fat diet mice (68, 80) may alternatively contribute to central inflammat…”
BackgroundDuca, F. A., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J., & Covasa, M. (2014) · Diabetes · doi:10.2337/db13-1526 · Cited by 161
“17 exhibited disruptions in tight junction protein levels, indicative of increased gut permeability(39).”
BackgroundRetractedComplex links between dietary lipids, endogenous endotoxins and metabolic inflammation
Laugerette, F., Vors, C., Peretti, N., & Michalski, M.-C. (2011) · Biochimie · doi:10.1016/j.biochi.2010.04.016 · Cited by 161
“has shown that antibiotic treatment modifies the gut microbiota, reduces 32 metabolic endotoxemia and the cecal content of LPS in both high fat-fed and ob/ob mice [5].”
BackgroundLiu, F., Prabhakar, M., Ju, J., Long, H., & Zhou, H.-W. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.156 · Cited by 160
Zhang, H.-Y., Tian, J.-X., Lian, F.-M., Li, M., Liu, W.-K., Zhen, Z., Liao, J.-Q., & Tong, X.-L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110857 · Cited by 161
The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Chidambaram, S. B., Rathipriya, A. G., Mahalakshmi, A. M., Sharma, S., Hediyal, T. A., Ray, B., Sunanda, T., Rungratanawanich, W., Kashyap, R. S., Qoronfleh, M. W., et al. (2022) · Cells · doi:10.3390/cells11071239 · Cited by 160
New insights into the mechanisms of high‐fat diet mediated gut microbiota in chronic diseases
Chen, J., Xiao, Y., Li, D., Zhang, S., Wu, Y., Zhang, Q., & Bai, W. (2023) · iMeta · doi:10.1002/imt2.69 · Cited by 161
“Cani et al. [62] also noted that obesity is closely linked to the reduction of Bifidobacteria .”
BackgroundShen, W., Gaskins, H. R., & McIntosh, M. K. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.009 · Cited by 160
Best practices for germ-free derivation and gnotobiotic zebrafish husbandry
(2017) · Methods in Cell Biology · doi:10.1016/bs.mcb.2016.11.005 · Cited by 157
Gut Microbiome Composition in Non-human Primates Consuming a Western or Mediterranean Diet
Nagpal, R., Shively, C. A., Appt, S. A., Register, T. C., Michalson, K. T., Vitolins, M. Z., & Yadav, H. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00028 · Cited by 159
“Mediterranean- and Western-type diets are well known to promote different metabolic phenotypes in several animal and human studies, wherein perturbations in the gut microbiome induced by western-style diets have been shown to play causal role in several gut-related diseases including adiposity, type 2 diabetes, and ot…”
BackgroundKe, X., Walker, A., Haange, S.-B., Lagkouvardos, I., Liu, Y., Schmitt-Kopplin, P., von Bergen, M., Jehmlich, N., He, X., Clavel, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.012 · Cited by 160
Visekruna, A., & Luu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703218 · Cited by 174
Toll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
“Animals started therapy after NAFLD/NASH had become established.”
InfluentialVitamin D: A new player in non-alcoholic fatty liver disease?
Eliades, M., & Spyrou, E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1718 · Cited by 181
Mafra, D., Lobo, J. C., Barros, A. F., Koppe, L., Vaziri, N. D., & Fouque, D. (2014) · Future Microbiology · doi:10.2217/fmb.13.165 · Cited by 157
Mathur, R., & Barlow, G. M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1051029 · Cited by 157
“Interestingly, altering the gut microbial profile using antibiotics was protective against the development of insulin resistance and increased fat weight, illustrating the key role of gut microbes in this phenomenon [76].”
BackgroundInfluentialGu, W., Wang, Y., Zeng, L., Dong, J.-C., Bi, Q., Yang, X., Che, Y., He, S., & Yu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109910 · Cited by 166
Eckardt, K., Taube, A., & Eckel, J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9168-2 · Cited by 181
“due to increased gut permeability, endotoxins potentially provide a molecular link between HFD and obesity-associated inflammation [10, 11].”
BackgroundKomazaki, R., Katagiri, S., Takahashi, H., Maekawa, S., Shiba, T., Takeuchi, Y., Kitajima, Y., Ohtsu, A., Udagawa, S., Sasaki, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14260-9 · Cited by 157
Effects of polysaccharides on glycometabolism based on gut microbiota alteration
Fang, Q., Hu, J., Nie, Q., & Nie, S. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.08.015 · Cited by 158
The gut vascular barrier: a new player in the gut–liver–brain axis
Brescia, P., & Rescigno, M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.007 · Cited by 175
Islam, M. R., Rauf, A., Akash, S., Trisha, S. I., Nasim, A. H., Akter, M., Dhar, P. S., Ogaly, H. A., Hemeg, H. A., Wilairatana, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116034 · Cited by 182
The Role of the Microbiome in Rheumatic Diseases
Yeoh, N., Burton, J. P., Suppiah, P., Reid, G., & Stebbings, S. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-012-0314-y · Cited by 155
“In one study, antibiotic administration reduced gut permeability and adipose tissue inflammation [87].”
BackgroundAngelakis, E., & Raoult, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010463 · Cited by 156
“and reduced metabolic endotoxemia and the cecal content of LPS in both highfat–fed and ob/ob mice [27].”
BackgroundToll-like receptor 4 modulates skeletal muscle substrate metabolism
Frisard, M. I., McMillan, R. P., Marchand, J., Wahlberg, K. A., Wu, Y., Voelker, K. A., Heilbronn, L., Haynie, K., Muoio, B., Li, L., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00307.2009 · Cited by 156
“Metabolic endotoxemia refers to a condition of increased circulating endotoxin levels in the blood of humans and rodents in states of obesity, type 2 diabetes, or in response to high fat feeding (8).”
BackgroundEffect of Functional Oligosaccharides and Ordinary Dietary Fiber on Intestinal Microbiota Diversity
Cheng, W., Lu, J., Li, B., Lin, W., Zhang, Z., Wei, X., Sun, C., Chi, M., Bi, W., Yang, B., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01750 · Cited by 154
“Maintaining the balance within the microbial community is essential for human health, and perturbation of this balance can induce diseases, including obesity, metabolic dysfunction, and immune system disorders (Cani et al., 2008; Vijay-Kumar et al., 2010; Frank et al., 2011; Wang et al., 2015).”
BackgroundLipopolysaccharide and the gut microbiota: considering structural variation
Mohr, A. E., Crawford, M., Jasbi, P., Fessler, S., & Sweazea, K. L. (2022) · FEBS Letters · doi:10.1002/1873-3468.14328 · Cited by 154
The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis
Hasani, A., Ebrahimzadeh, S., Hemmati, F., Khabbaz, A., Hasani, A., & Gholizadeh, P. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001435 · Cited by 152
Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls
Deng, Y., Wang, H., Zhou, J., Mou, Y., Wang, G., & Xiong, X. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-2968 · Cited by 154
Xin, J., Zeng, D., Wang, H., Ni, X., Yi, D., Pan, K., & Jing, B. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5752-1 · Cited by 176
“Inflammation induced by LPS is essential for these phenotypes because CD14-knockout mice avoided the development of obesity and IR after LPS infusion (Cani et al. 2008).”
BackgroundSong, H., Chu, Q., Yan, F., Yang, Y., Han, W., & Zheng, X. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13278 · Cited by 154
Song, J.-X., Ren, H., Gao, Y., Lee, C., Li, S., Zhang, F., Li, L., & Chen, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00602 · Cited by 166
“, 2013) and systemic low-grade inflammation (Cani et al., 2008; Vijay-Kumar et al., 2010; Fei and Zhao, 2013).”
BackgroundInfluentialCremonini, E., Wang, Z., Bettaieb, A., Adamo, A. M., Daveri, E., Mills, D. A., Kalanetra, K. M., Haj, F. G., Karakas, S. E., & Oteiza, P. I. (2017) · Redox Biology · doi:10.1016/j.redox.2017.11.002 · Cited by 161
Effects of short chain fatty acids on metabolic and inflammatory processes in human health
Campos-Perez, W. Y., & Martínez‐López, E. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158900 · Cited by 184
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease
Lai, H.-C., Young, J., Lin, C.-S., Chang, C.-J., Lu, C.-C., Martel, J., Ojcius, D., & Ko, Y.-F. (2014) · Biomedical Journal · doi:10.4103/2319-4170.138314 · Cited by 153
“Antibiotic treatment in high-fat-fed mice and ob/ob mice reduces the LPS levels in blood and feces.([57]) Taken together, these studies suggest that intestinal microbes may contribute to obesity by inducing chronic inflammation.”
BackgroundGangarapu, V., Ince, A. T., Baysal, B., Kayar, Y., Klç, U., Gök, Ö., Uysal, Ö., & Şenturk, H. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000348 · Cited by 153
The Infant Gut Microbiome: Evidence for Obesity Risk and Dietary Intervention
Koleva, P., Bridgman, S., & Kozyrskyj, A. (2015) · Nutrients · doi:10.3390/nu7042237 · Cited by 153
“and insulin resistance in these mice [14,58].”
BackgroundGut microbiome and metabolic diseases
Fukuda, S., & Ohno, H. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0399-z · Cited by 170
“Collectively, these animal studies indicate that the gut microbiota can induce fatty liver through an increase in monosaccharide absorption [76], hepatotoxic ethanol production [38], microbial endotoxin-induced low-grade chronic inflammation [30, 44, 71], as well as modulation of bile acid metabolism [72].”
BackgroundRibière, C., Peyret, P., Parisot, N., Darcha, C., Déchelotte, P. J., Barnich, N., Peyretaillade, É., & Boucher, D. (2016) · Scientific Reports · doi:10.1038/srep31027 · Cited by 167
Lee, P., Yacyshyn, B. R., & Yacyshyn, M. B. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13561 · Cited by 151
“colipid, can cause systemic low-grade inflammation, which can precipitate obesity and diabetes.(19,66) HFD-fed mice exhibited a disrupted”
BackgroundInfluentialDorenkott, M. R., Griffin, L. E., Goodrich, K. M., Thompson‐Witrick, K. A., Fundaro, G., Ye, L., Stevens, J. R., Ali, M. M., O’Keefe, S. F., Hulver, M. W., et al. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500333y · Cited by 170
Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health
Bansal, A., Henao-Mejia, J., & Simmons, R. A. (2018) · Endocrinology · doi:10.1210/en.2017-00882 · Cited by 152
Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System
Parolini, C. (2019) · Marine Drugs · doi:10.3390/md17060374 · Cited by 169
Gut Microbiota and Its Mysteries
Pushpanathan, P., Mathew, G. S., Selvarajan, S., Seshadri, K., & Srikanth, P. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_19_373 · Cited by 169
Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation
Arifuzzaman, M., Collins, N., Guo, C., & Artis, D. (2024) · Immunity · doi:10.1016/j.immuni.2023.12.009 · Cited by 169
High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability
Johnson, A. M. F., Costanzo, A., Gareau, M. G., Armando, A. M., Quehenberger, O., Jameson, J. M., & Olefsky, J. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122195 · Cited by 150
“gastrointestinal tract may play an etiologic role in driving systemic inflammation [1,2,4].”
BackgroundMethodInfluentialSchizophrenia and the gut–brain axis
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.018 · Cited by 151
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2018) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 151
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.